Dai Fukumura

18PUBLICATIONS
111CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 15, 2025
Wnt inhibition alleviates resistance to anti-PD1 therapy and improves antitumor immunity in glioblastoma.

Shanmugarajan Krishnan, Somin Lee, Zohreh Amoozgar

|May 24, 2025
IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against pancreatic cancer in mice with obesity.

|Jan 23, 2024
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy.

Jiang Chen, Zohreh Amoozgar, Xin Liu

|Jan 18, 2024
Wnt inhibition alleviates resistance to immune checkpoint blockade in glioblastoma.

Rakesh Jain, Shanmugarajan Krishnan, Somin Lee

|Mar 10, 2023
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice.

Xinyue Dong, Jun Ren, Zohreh Amoozgar

|Feb 07, 2023
Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer.

Yves Boucher, Jessica M Posada, Sonu Subudhi

Pageof 3

Frequent Collaborators

17 joint publications

Rakesh K Jain

7 joint publications

Dan G Duda

4 joint publications

Zohreh Amoozgar

4 joint publications

Meenal Datta